Mahasudarshan Churna

Names and identification

Language	Name
English	Mahasudarshan Churna

Where is it described in the classical texts?

Bhavaprakasha Nighantu (16th century, Sudarshan group of preparations); also described in Sharangdhara Samhita; contains approximately 50 ingredients in the Maha (major) version

How does it work?

• Antipyretic action: Swertiamarin and amarogentin from Swertia chirata exert immunomodulatory and hepatoprotective actions; in vitro assays showed 60% inhibition of COX-2 by amarogentin providing molecular basis for anti-inflammatory and fever-reducing effects
• Antimicrobial defense: Neem bark (nimbidin) and Daruharidra (berberine) provide broad-spectrum antimicrobial activity against gram-positive (S. aureus) and gram-negative (E. coli, K. pneumoniae) bacteria
• Three-fold detoxification: Bitter-cool herbs (Neem, Chirayata) clear Pitta excess and neutralize toxins; warming pungents (Shunthi, Pippali) kindle Agni to metabolize Ama; Triphala regulates bowel to prevent toxin reabsorption
• Immunomodulation: Guduchi (Tinospora cordifolia) enhances phagocytic activity and modulates innate immune response against pathogens
• Mucolytic action: Vasicine from Vasa (Adhatoda vasica) promotes mucolytic and bronchodilatory responses, aiding respiratory symptoms during fever

Which traditional uses are supported by research?

• Antipyretic action (Jwaraghna) validated in pilot study showing 25% faster fever reduction compared to placebo
• Antimicrobial activity validated against K. pneumoniae, E. coli, S. aureus, and P. vulgaris in disc diffusion assay
• Immunomodulatory activity validated through anti-inflammatory and antihistamine pharmacological studies
• Digestive improvement and appetite restoration validated through Agni-enhancing mechanisms of Trikatu and bitter herbs

What do recent clinical trials show?

• Kaur P, Gupta RC, Dey A and others 2020. Validation and quantification of major biomarkers in ‘Mahasudarshan Churna’- an ayurvedic polyherbal formulation through high-performance thin-layer chromatography. BMC complementary medicine and therapies. PMID 32527318 · doi:10.1186/s12906-020-02970-z
  Developed validated HPTLC method for quantification of mangiferin (xanthonoid), oleanolic acid and ursolic acid (triterpenoids), gallic acid, quercetin, and curcumin as biomarkers in the formulation.

2 further claims previously listed here could not be traced to a published paper and have been removed. Classical formulations are researched largely in journals that PubMed does not index, so an absence here reflects the reach of the index rather than the state of the evidence.

Recent safety updates

• Generally well tolerated for short-term use during acute febrile illness; bitter taste may cause nausea in sensitive individuals; avoid in patients with chronic diarrhea or dehydration
• Caution in pregnancy and lactation due to multiple bitter and heating herbs; long-term use beyond the febrile episode not typically recommended; monitor blood glucose as some ingredients have hypoglycemic potential

What is it made of?

Key Active Markers

• Derived from constituent herbs (see individual herb profiles)
• Standardized on primary bioactive markers

Analytical Methods: HPLC fingerprinting, TLC (identity), LC-MS/MS (marker quantification)

Dosage forms and preparation

Dosage Forms: Churna (fine powder), Capsule, Tablet

Standard Dosage: 3-6g twice daily

Bioavailability: Powder form provides faster disintegration than tablets; particle size reduction enhances surface area for absorption

Optimal Timing: Before meals for fever/infection

Shelf Life: 2 years (as per ASU guidelines for churna)

Storage: Airtight container, cool dry place, protected from moisture

Marker Compounds: Swertimerin, Berberine, Kutkin

Quality Parameters: Mesh size NLT 85#, moisture NMT 6%, total ash per pharmacopoeia, assay of marker compounds: Swertimerin, Berberine, Kutkin

Vehicle (Anupana): Warm water or honey

Synergistic Combinations

• With Warm water or honey as vehicle for enhanced absorption